About this trial
The purpose of this study is to investigate the effect of mango intake on metabolic and inflammatory responses relative to meals in individuals at risk of developing diabetes, as well as to understand how the beneficial compounds found in mangoes are absorbed and processed in the body.
Eligibility criteria
Qualifiers
Be between 20-60 years old.
Have a BMI of 25-35 kilograms per square meter.
Have fasting blood glucose between 100-125 milligrams per deciliter or Glycated hemoglobin (HbA1c) between 5.7-6.4%.
Be non-smokers for at least 12 months.
Disqualifiers
Smoke, vape, or use marijuana.
Have allergies or intolerance to mangoes or study foods.
Have blood pressure above 160/100 millimeters of Mercury.
Have fasting blood glucose above 125 milligrams per deciliter.
Trial design
Treatments tested in this trial
- Mango
- Control Beverage
Treatment groups
Sponsors and collaborators
Clinical Nutrition Research Center, Illinois Institute of Technology
Lead sponsor
National Mango Board
Collaborator